Patents Assigned to Scriptgen Pharmaceuticals
  • TFIIB transcription factor from Candida albicans and methods of screening for inhibitors of Candida albicans growth
    Patent number: 6300067
    Abstract: The invention encompasses a novel transcription factor from Candida albicans, TFIIB, a nucleic acid sequence encoding TFIIB, and methods of screening for inhibitors of Candida albicans growth by targeting TFIIB.
    Type: Grant
    Filed: December 3, 1998
    Date of Patent: October 9, 2001
    Assignees: Scriptgen Pharmaceuticals, Harvard College, President & Fellows
    Inventors: Stephen Buratowski, C. Richard Wobbe, John Douglas Bradley